DALLAS, July 7, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2022, after the market closes on Aug. 1, 2022. The Company will host its first investor conference call as an independent, publicly traded company to discuss its results for the quarter at 11 a.m. ET on Aug. 2, 2022.

(PRNewsfoto/Enhabit Home Health & Hospice)

The conference call may be accessed by dialing 888-660-6150 and giving the conference ID 5248158. International callers may dial 929-203-0843 and give the same conference ID. Please dial in approximately 10 minutes before the start of the call to ensure you are connected.

A live webcast of the conference call and an online replay of the conference call can be found on the Company's investor website at https://investors.ehab.com. 

About Enhabit Home Health & Hospice  

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what's possible for patient care in the home. The company's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 99 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.  

Media contact
Erin Volbeda
media@ehab.com
972-338-5141

Investor relations contact
Jennifer Hills
jennifer.hills@ehab.com
469-621-6496

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/enhabit-home-health--hospice-announces-date-of-2022-second-quarter-earnings-call-301581857.html

SOURCE Enhabit Home Health & Hospice

Copyright 2022 PR Newswire

Enhabit (NYSE:EHAB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Enhabit Charts.
Enhabit (NYSE:EHAB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Enhabit Charts.